Aripiprazole for the Augmentation of Antidepressant Therapy
Status:
Completed
Trial end date:
2013-05-01
Target enrollment:
Participant gender:
Summary
The study aims to evaluate effectiveness and tolerability of aripiprazole augmentation in
outpatients with major depressive disorder who have had inadequate response to
antidepressants in Taiwan clinical practice.